HAVN Life Sciences Inc (OTCMKTS:HAVLF) is a brand new public company with a mission to be the future of psychedelic medicine. The shroom boom is in full effect, so we sat down to talk about how HAVN is differentiating itself within this emerging space.
Former Aphria Inc (NASDAQ:APHA) CEO, former Jamieson Wellness Inc (TSE:JWEL) CEO, and now HAVN Life Sciences Executive Chairman Vic Neufeld has vast experience in both the health & wellness and once-illegal drug space. We sat down with Vic to discuss his new tenure and his thoughts on the psychedelic market.
We discuss the key compounds HAVN is using which elicit the best response for illnesses such as PTSD, anxiety, depression, addiction, and more… We also find out about the company’s natural health products, using non-magic mushroom, custom formulations to support healthy bodily functions.
Watch this exclusive interview to find out the latest from HAVN Life Sciences and psychedelic medicines.